Literature DB >> 20944664

Engineering the perfect (bacterial) cancer therapy.

Neil S Forbes1.   

Abstract

Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944664      PMCID: PMC3756932          DOI: 10.1038/nrc2934

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  133 in total

1.  Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.

Authors:  C Clairmont; K C Lee; J Pike; M Ittensohn; K B Low; J Pawelek; D Bermudes; S M Brecher; D Margitich; J Turnier; Z Li; X Luo; I King; L M Zheng
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

2.  Antitumor effect of Bifidobacterium infantis in mice.

Authors:  Y Kohwi; K Imai; Z Tamura; Y Hashimoto
Journal:  Gan       Date:  1978-10

3.  Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters.

Authors:  S Nuyts; L Van Mellaert; S Barbé; E Lammertyn; J Theys; W Landuyt; E Bosmans; P Lambin; J Anné
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

4.  Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector.

Authors:  L M Zheng; X Luo; M Feng; Z Li; T Le; M Ittensohn; M Trailsmith; D Bermudes; S L Lin; I C King
Journal:  Oncol Res       Date:  2000       Impact factor: 5.574

5.  Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models.

Authors:  Li-Jun Jia; Dong-Ping Wei; Qi-Ming Sun; Yan Huang; Qiang Wu; Zi-Chun Hua
Journal:  Cancer Sci       Date:  2007-05-13       Impact factor: 6.716

6.  Containment of tumor-colonizing bacteria by host neutrophils.

Authors:  Kathrin Westphal; Sara Leschner; Jadwiga Jablonska; Holger Loessner; Siegfried Weiss
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

7.  Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth.

Authors:  Markus Loeffler; Gaelle Le'Negrate; Maryla Krajewska; John C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

8.  Attenuated bacteria as effectors in cancer immunotherapy.

Authors:  Basel K Al-Ramadi; Maria J Fernandez-Cabezudo; Hussain El-Hasasna; Suhail Al-Salam; Samir Attoub; Damo Xu; Salem Chouaib
Journal:  Ann N Y Acad Sci       Date:  2008-09       Impact factor: 5.691

9.  Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.

Authors:  J Fensterle; B Bergmann; C L R P Yone; C Hotz; S R Meyer; S Spreng; W Goebel; U R Rapp; I Gentschev
Journal:  Cancer Gene Ther       Date:  2007-12-14       Impact factor: 5.987

10.  Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice.

Authors:  Chisa Nagakura; Katsuhiro Hayashi; Ming Zhao; Kensuke Yamauchi; Norio Yamamoto; Hiroyuki Tsuchiya; Katsuro Tomita; Michael Bouvet; Robert M Hoffman
Journal:  Anticancer Res       Date:  2009-06       Impact factor: 2.480

View more
  210 in total

1.  A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.

Authors:  Kelly Flentie; Brandon Kocher; Seth T Gammon; Deborah V Novack; Jeffrey S McKinney; David Piwnica-Worms
Journal:  Cancer Discov       Date:  2012-05-03       Impact factor: 39.397

2.  Editorial on "Cancer and the microbiota" published in Science.

Authors:  Alison K Hamm; Tiffany L Weir
Journal:  Ann Transl Med       Date:  2015-08

3.  Modeling of chemotactic steering of bacteria-based microrobot using a population-scale approach.

Authors:  Sunghoon Cho; Young Jin Choi; Shaohui Zheng; Jiwon Han; Seong Young Ko; Jong-Oh Park; Sukho Park
Journal:  Biomicrofluidics       Date:  2015-09-30       Impact factor: 2.800

4.  To Study the Anti-cancer Effects of Shigella Flexneri in AspC-1 Pancreatic Cancer Cell Line in Approach to Bax and bcl-2 Genes.

Authors:  Amir Khodavirdipour; Fahimeh Jamshidi; Hamideh Rouhani Nejad; Masoud Zandi; Rana Zarean
Journal:  J Gastrointest Cancer       Date:  2021-06

5.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.

Authors:  Mauro Castellarin; René L Warren; J Douglas Freeman; Lisa Dreolini; Martin Krzywinski; Jaclyn Strauss; Rebecca Barnes; Peter Watson; Emma Allen-Vercoe; Richard A Moore; Robert A Holt
Journal:  Genome Res       Date:  2011-10-18       Impact factor: 9.043

6.  Cell Labeling with Magneto-Endosymbionts and the Dissection of the Subcellular Location, Fate, and Host Cell Interactions.

Authors:  Kayla R Lee; Abdul Wakeel; Papia Chakraborty; Chandler S Foote; Lauren Kajiura; Joyce C Barrozo; Andrea C Chan; Alexey V Bazarov; Ryan Spitler; Peter M Kutny; Jim M Denegre; Rob A Taft; Joachim Seemann; Bradley W Rice; Christopher H Contag; Brian K Rutt; Caleb B Bell
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

7.  Bottom-up approaches in synthetic biology and biomaterials for tissue engineering applications.

Authors:  Mitchell S Weisenberger; Tara L Deans
Journal:  J Ind Microbiol Biotechnol       Date:  2018-03-19       Impact factor: 3.346

8.  Targeted deletion of the ara operon of Salmonella typhimurium enhances L-arabinose accumulation and drives PBAD-promoted expression of anti-cancer toxins and imaging agents.

Authors:  Hyun Hong; Daejin Lim; Geun-Joong Kim; Seung-Hwan Park; Hyeon Sik Kim; Yeongjin Hong; Hyon E Choy; Jung-Joon Min
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  Recent trends and advances in microbe-based drug delivery systems.

Authors:  Pravin Shende; Vasavi Basarkar
Journal:  Daru       Date:  2019-08-02       Impact factor: 3.117

Review 10.  Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy.

Authors:  Anne M Macpherson; Simon C Barry; Carmela Ricciardelli; Martin K Oehler
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.